Elevance Health, Inc. (ELV) To Go Ex-Dividend on March 10th

Elevance Health, Inc. (NYSE:ELV) declared a quarterly dividend on Tuesday, January 27th. Stockholders of record on Tuesday, March 10th will be paid a dividend of 1.72 per share on Wednesday, March 25th. This represents a c) annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, March 10th. This is a 0.6% increase from Elevance Health’s previous quarterly dividend of $1.71.

Elevance Health has raised its dividend by an average of 0.1%annually over the last three years and has increased its dividend every year for the last 14 years. Elevance Health has a payout ratio of 17.5% meaning its dividend is sufficiently covered by earnings. Research analysts expect Elevance Health to earn $39.05 per share next year, which means the company should continue to be able to cover its $6.88 annual dividend with an expected future payout ratio of 17.6%.

Elevance Health Trading Up 1.1%

ELV opened at $289.56 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.54 and a quick ratio of 1.54. The company has a market cap of $63.91 billion, a price-to-earnings ratio of 11.53, a price-to-earnings-growth ratio of 1.60 and a beta of 0.51. The firm has a 50 day simple moving average of $344.64 and a 200 day simple moving average of $335.17. Elevance Health has a fifty-two week low of $273.71 and a fifty-two week high of $458.75.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Wednesday, January 28th. The company reported $3.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.10 by $0.23. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. The firm had revenue of $49.31 billion for the quarter, compared to analysts’ expectations of $49.52 billion. During the same period last year, the firm earned $3.84 earnings per share. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. Elevance Health has set its FY 2026 guidance at 25.500- EPS. On average, sell-side analysts anticipate that Elevance Health will post 33.96 earnings per share for the current year.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.